Stage 1 IRVAN syndrome in an asymptomatic female with BRIP1 mutation
Аннотация
Publication date: October 2026 Source: Canadian Journal of Ophthalmology, Volume 61, Issue 5 Author(s): Nicholas Strobl, Carolina C.S. Valentim, Melis Kabaalioglu Guner
Publication date: October 2026 Source: Canadian Journal of Ophthalmology, Volume 61, Issue 5 Author(s): Nicholas Strobl, Carolina C.S. Valentim, Melis Kabaalioglu Guner
Acta Ophthalmologica, EarlyView.
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Clinical &Experimental Ophthalmology, EarlyView.
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...